Genesis Healthcare, Inc., together with its subsidiaries, owns and operates skilled nursing facilities and assisted/senior living facilities in the United States. The company operates through three segments: Inpatient Services, Rehabilitation Therapy Services, and All Other Services. It also provides a range of rehabilitation therapy services, including speech-language pathology, physical therapy, occupational therapy, and respiratory therapy. In addition, the company offers other specialty medical services, such as physician, staffing, and other healthcare related services. As of December 31, 2017, it provided inpatient services through a network of 470 skilled nursing and assisted/senior living facilities, including 444 skilled nursing facilities and 26 stand-alone assisted/senior living facilities across 30 states. Genesis HealthCare, Inc. also supplied rehabilitation and respiratory therapy to approximately 1,600 healthcare locations in 46 states and the District of Columbia. The company was formerly known as FC-GEN Operations Investment, LLC and changed its name to Genesis HealthCare, Inc. in February 2015. Genesis HealthCare, Inc. was founded in 2003 and is headquartered in Kennett Square, Pennsylvania.
Industry, Sector and Symbol
Stock Exchange NYSE
Industry Skilled nursing care facilities
Sub-IndustryN/A
SectorMedical
SymbolNYSE:GEN
CUSIPN/A
Phone610-444-6350
Debt
Debt-to-Equity Ratio-2.80
Current Ratio1.11
Quick Ratio1.11
Price-To-Earnings
Trailing P/E Ratio-0.69
Forward P/E Ratio-1.27
P/E GrowthN/A
Sales & Book Value
Annual Sales$5.37 billion
Price / Sales0.04
Cash Flow$2.7037 per share
Price / Cash0.54
Book Value($10.54) per share
Price / Book-0.14
Profitability
EPS (Most Recent Fiscal Year)($2.11)
Net Income$-578,980,000.00
Net Margins-11.29%
Return on EquityN/A
Return on Assets-2.73%
Miscellaneous
Employees68,700
Outstanding Shares159,450,000
Market Cap$226.41
Genesis Healthcare (NYSE:GEN) Frequently Asked Questions
What is Genesis Healthcare's stock symbol?
Genesis Healthcare trades on the New York Stock Exchange (NYSE) under the ticker symbol "GEN."
How were Genesis Healthcare's earnings last quarter?
Genesis Healthcare Inc (NYSE:GEN) issued its quarterly earnings data on Thursday, May, 10th. The company reported ($0.70) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.36) by $0.34. The firm had revenue of $1.30 billion for the quarter, compared to analysts' expectations of $1.32 billion. During the same period last year, the firm posted ($0.55) earnings per share. View Genesis Healthcare's Earnings History.
What price target have analysts set for GEN?
3 brokerages have issued 1-year price objectives for Genesis Healthcare's shares. Their forecasts range from $2.00 to $2.00. On average, they expect Genesis Healthcare's share price to reach $2.00 in the next year. This suggests a possible upside of 37.0% from the stock's current price. View Analyst Ratings for Genesis Healthcare.
What is the consensus analysts' recommendation for Genesis Healthcare?
3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Genesis Healthcare in the last year. There are currently 3 hold ratings for the stock, resulting in a consensus recommendation of "Hold."
Who are some of Genesis Healthcare's key competitors?
Some companies that are related to Genesis Healthcare include TG Therapeutics Inc common stock (TGTX), Knight Therapeutics (KHTRF), Rhythm Pharmaceuticals (RYTM), Triple-S Management (GTS), Assembly Biosciences (ASMB), Autolus Therapeutics (AUTL), Spire Healthcare Group (SPI), Genfit (GNFTF), Amarin (AMRN), ANI Pharmaceuticals Inc Common Stock (ANIP), Stratec Biomedical (SBS), Kindred Healthcare (KND), Inflarx (IFRX), Mesa Laboratories (MLAB) and Mesoblast (MSB).
Who are Genesis Healthcare's key executives?
Genesis Healthcare's management team includes the folowing people:
- Mr. George V. Hager Jr., Chief Exec. Officer and Director (Age 62)
- Mr. Thomas DiVittorio, Chief Financial Officer, Sr. VP, Treasurer and Assistant Sec. (Age 50)
- Dr. JoAnne Susan Reifsnyder Ph.D., MSN, MBA, FAAN, Exec. VP of Clinical Operations & Chief Nursing Officer (Age 59)
- Mr. Paul David Bach, Chief Operating Officer and Exec. VP (Age 59)
- Mr. Richard L. Castor, Chief Information Officer & Sr. VP (Age 63)
Has Genesis Healthcare been receiving favorable news coverage?
News coverage about GEN stock has trended somewhat positive this week, Accern reports. Accern rates the sentiment of media coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Genesis Healthcare earned a coverage optimism score of 0.14 on Accern's scale. They also assigned news coverage about the company an impact score of 47.08 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company's share price in the immediate future.
How do I buy shares of Genesis Healthcare?
Shares of GEN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Genesis Healthcare's stock price today?
One share of GEN stock can currently be purchased for approximately $1.46.
How big of a company is Genesis Healthcare?
Genesis Healthcare has a market capitalization of $226.41 million and generates $5.37 billion in revenue each year. The company earns $-578,980,000.00 in net income (profit) each year or ($2.11) on an earnings per share basis. Genesis Healthcare employs 68,700 workers across the globe.
How can I contact Genesis Healthcare?
Genesis Healthcare's mailing address is 101 EAST STATE STREET, KENNETT SQUARE PA, 19348. The company can be reached via phone at 610-444-6350 or via email at [email protected]
MarketBeat Community Rating for Genesis Healthcare (NYSE GEN)
MarketBeat's community ratings are surveys of what our community members think about Genesis Healthcare and other stocks. Vote "Outperform" if you believe GEN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GEN will underperform the S&P 500 over the long term. You may vote once every thirty days.
